Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

作者：Cristina Grávalos, Carlos Gómez-Martín, Fernando Rivera, Inmaculada Alés, Bernardo Queralt, Antonia Márquez, Ulpiano Jiménez, Vicente Alonso, Rocio García‐Carbonero, Javier Sastre, Rámón Colomer, H. Cortés-Funes, Antonio Jimeno · 发表于：Clinical & Translational Oncology · 年份：2011 · DOI：10.1007/s12094-011-0637-6 · 被引用次数：80 · 研究领域：HER2/EGFR in Cancer Research、Gastric Cancer Management and Outcomes、Esophageal Cancer Research and Treatment